Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study-Reference-Cited by-同舟云学术

Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study

Published:2014-07-20 Issue:3 Volume:74 Page:503-509
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Zheng Yulong,Fang Weijia,Mao Chenyu,Qian Joing,Zhao Peng,Zhang Xiaochen,Jiang Haiping,Zheng Yi,Xu Nong

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-014-2537-2.pdf

Reference33 articles.

1. Zhu X, Li J (2010) Gastric carcinoma in China: current status and future perspectives (Review). Oncol Lett 1(3):407–412. doi: 10.3892/ol_00000071

2. Cervantes A, Roda D, Tarazona N, Rosello S, Perez-Fidalgo JA (2013) Current questions for the treatment of advanced gastric cancer. Cancer Treat Rev 39(1):60–67. doi: 10.1016/j.ctrv.2012.09.007

3. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24(31):4991–4997. doi: 10.1200/JCO.2006.06.8429

4. Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9(3):215–221. doi: 10.1016/S1470-2045(08)70035-4

5. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, Fleig WE (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev (3):CD004064. doi: 10.1002/14651858.CD004064.pub3

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer;OncoTargets and Therapy;2022-03

2. OncoVee™-MiniPDX-Guided Anticancer Treatment for Gastric Cancer Patients With Synchronous Liver Metastases: A Retrospective Cohort Analysis;Frontiers in Oncology;2022-01-03

3. Evolving treatments for advanced gastric cancer: appraisal of the survival trend;Expert Review of Anticancer Therapy;2016-05-23

4. Second-line treatment of metastatic gastric cancer: Current options and future directions;World Journal of Gastroenterology;2015